ATLAS / Macro Radar / Reporting / ENVB

Enveric Biosciences, Inc. (ENVB) reporting calendar

Enveric Biosciences, Inc. files periodic reports with the SEC as ENVB on Nasdaq. Atlas tracks 101 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
23 Jul 2026 – 5 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
15 May 2026
Reports on record
101

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 45 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open ENVB market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202615 May 202645 days0001493152-26-023353
10-K31 Dec 202527 Mar 202686 days0001493152-26-013294
10-Q30 Sep 202514 Nov 202545 days0001493152-25-023540
10-Q30 Jun 202514 Aug 202545 days0001641172-25-024021
10-Q31 Mar 202514 May 202544 days0001641172-25-010345
10-K31 Dec 202428 Mar 202587 days0001641172-25-001296
10-Q30 Sep 202414 Nov 202445 days0001493152-24-045859
10-Q30 Jun 202412 Aug 202443 days0001493152-24-031352
10-Q31 Mar 202415 May 202445 days0001493152-24-019364
10-K31 Dec 202326 Mar 202486 days0001493152-24-011210
10-Q30 Sep 202313 Nov 202344 days0001493152-23-040493
10-Q30 Jun 202311 Aug 202342 days0001493152-23-027881
10-Q31 Mar 202315 May 202345 days0001493152-23-016990
10-K31 Dec 202231 Mar 202390 days0001493152-23-010431
10-Q30 Sep 202214 Nov 202245 days0001493152-22-032131
10-Q30 Jun 202212 Aug 202243 days0001493152-22-022369
10-Q31 Mar 202213 May 202243 days0001493152-22-013332
10-K31 Dec 202131 Mar 202290 days0001493152-22-008510
10-Q30 Sep 202115 Nov 202146 days0001493152-21-028263
10-Q30 Jun 202113 Aug 202144 days0001493152-21-019738
10-Q31 Mar 202117 May 202147 days0001493152-21-011946
10-K31 Dec 20201 Apr 202191 days0001493152-21-007757
10-Q30 Sep 202016 Nov 202047 days0001493152-20-021409
10-Q30 Jun 202014 Aug 202045 days0001493152-20-015855
10-Q31 Mar 202015 May 202045 days0001567619-20-010243
10-K31 Dec 201925 Mar 202085 days0001140361-20-006825
10-Q30 Sep 20198 Nov 201939 days0001140361-19-020187
10-Q30 Jun 201914 Aug 201945 days0001140361-19-014987
10-Q31 Mar 201914 May 201944 days0001140361-19-009043
10-K31 Dec 201826 Mar 201985 days0001140361-19-005573
10-Q30 Sep 201814 Nov 201845 days0001140361-18-043114
10-Q30 Jun 201814 Aug 201845 days0001140361-18-036289
10-Q31 Mar 201815 May 201845 days0001140361-18-023478
10-K31 Dec 20172 Apr 201892 days0001140361-18-016275
10-Q30 Sep 201713 Nov 201744 days0001140361-17-042135
10-Q30 Jun 201714 Aug 201745 days0001140361-17-031753
10-Q31 Mar 201712 May 201742 days0001140361-17-020046
10-K31 Dec 201631 Mar 201790 days0001079974-17-000125
10-Q30 Sep 201614 Nov 201645 days0001079974-16-001683
10-Q30 Jun 201612 Aug 201643 days0001079974-16-001485

Source: SEC EDGAR company submissions for CIK 0000890821. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.